Trinity Biotech PLC (FRA:TRB)
€ 2.12 0 (0%) Market Cap: 20.08 Mil Enterprise Value: 79.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q3 2019 Trinity Biotech PLC Earnings Call Transcript

Oct 16, 2019 / 03:00PM GMT
Release Date Price: €4.58 (+15.09%)
Operator

Good day, and welcome to the Trinity Biotech Third Quarter Fiscal Year 2019 Results Conference Call. (Operator Instructions)

Please note this event is being recorded.

I would now like to turn the conference over to Joe Diaz with Lytham Partners. Please go ahead.

Joe Diaz
Lytham Partners, LLC - Managing Partner

Thank you, Nicole, and thanks all of you for joining us to review the financial results of Trinity Biotech for the third quarter of fiscal year 2019, which ended September 30, 2019.

With us on the call representing the company are Ronan OâCaoimh, Chief Executive Officer; and Kevin Tansley, Chief Financial Officer.

At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session. Before we begin with those prepared statements, we submit for the record, the following statement. Statements made by the management team of Trinity Biotech during the course of this conference call that are not historical facts are considered to be forward-looking statements subject to risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot